Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Accenture
Teva
Chubb
McKesson
Fish and Richardson
US Army
Chinese Patent Office
Medtronic
QuintilesIMS

Generated: June 19, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 061212

« Back to Dashboard

NDA 061212 describes BACITRACIN, which is a drug marketed by Akorn, Fresenius Kabi Usa, Mylan Asi, Pfizer, Pharmacia And Upjohn, Xellia Pharms Aps, Lilly, Perrigo Co Tennessee, Pharmaderm, Pharmafair, Combe, Naska, Apothekernes, Paddock Llc, Bausch And Lomb, and Altana, and is included in twenty-three NDAs. It is available from nine suppliers. Additional details are available on the BACITRACIN profile page.

The generic ingredient in BACITRACIN is bacitracin zinc; hydrocortisone acetate; neomycin sulfate; polymyxin b sulfate. There are twenty-seven drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the bacitracin zinc; hydrocortisone acetate; neomycin sulfate; polymyxin b sulfate profile page.
Summary for 061212
Tradename:BACITRACIN
Applicant:Perrigo Co Tennessee
Ingredient:bacitracin
Patents:0
Therapeutic Class:Antibacterials
Formulation / Manufacturing:see details
Pharmacology for NDA: 061212
Medical Subject Heading (MeSH) Categories for 061212
Suppliers and Packaging for NDA: 061212
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
BACITRACIN bacitracin OINTMENT;OPHTHALMIC 061212 ANDA Paddock Laboratories, LLC 0574-4022 N 0574-4022-01
BACITRACIN bacitracin OINTMENT;OPHTHALMIC 061212 ANDA Paddock Laboratories, LLC 0574-4022 N 0574-4022-13

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:OINTMENT;OPHTHALMICStrength500 UNITS/GM
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Harvard Business School
AstraZeneca
Daiichi Sankyo
Deloitte
Fish and Richardson
Mallinckrodt
Johnson and Johnson
QuintilesIMS
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.